Who writes this
Every guide is written, edited, and maintained by the HRT AI product team. HRT AI is the developer of the HRT AI iPhone app, a private symptom and dose tracker for people going through perimenopause, menopause, surgical menopause, premature ovarian insufficiency, or gender-affirming hormone therapy. You can reach the team directly at contact@hrtai.app.
We are not clinicians, and no page on this site is reviewed by one. We do not employ a medical reviewer, and we are not going to put a fictional credential at the top of an article to make it look like we do. What we do have is the thing a software team legitimately knows about: how people actually record symptoms over months, what makes a log fall apart, and what a clinician can and cannot do with the notes someone brings to an appointment.
That is the boundary of our expertise, and it is the boundary of what we write about. We write about observing and recording. We do not write about treating.
How each page is sourced
Every guide ends with a numbered Sources list, and every clinical statement in the body traces back to one of those entries. We use four kinds of source, in this order of preference:
- National clinical guidance. NICE guideline NG23 (Menopause: identification and management) and NHS patient guidance are our default reference for definitions, diagnosis, and what the options are.
- Professional-body position statements. The American College of Obstetricians and Gynecologists (ACOG), The Menopause Society (formerly NAMS), the British Menopause Society, ESHRE for premature ovarian insufficiency, and WPATH plus the Endocrine Society for gender-affirming care.
- Peer-reviewed research indexed in PubMed. Used for specific findings — for example the Study of Women's Health Across the Nation (SWAN) analyses of how long vasomotor symptoms last.
- Regulator-approved product information. FDA labels and equivalent national summaries of product characteristics, when the question is about how a formulation is used rather than whether it should be.
We link to the source itself rather than to somebody else's summary of it. Where guidance from different countries disagrees, we say that it disagrees instead of picking the version that reads better.
Every page carries a visible published date and a last reviewed date at the top. When guidance changes, we update the page and move the review date. We do not re-date pages we have not actually re-read.
Four things we will never publish
Doses
No milligrams, micrograms, patch strengths, injection volumes, or titration schedules — not as a recommendation, not as an example, not as a "typical starting point". Dose belongs to the person prescribing it, who knows your history, your other medicines, and your risk factors. We name routes and formulations; we never quantify them.
Treatment recommendations
We will not tell you to start HRT, to stop it, to switch routes, to add or drop a progestogen, or to try a supplement. We describe what the options are called and what published guidance says about them, which is a different act from telling you what to do.
Outcome promises
No page will claim that tracking, or the app, or any therapy will reduce your symptoms by a given amount or on a given timeline. Symptom trajectories vary enormously between people. Where we cite a number, it is a published population finding with the study named — not a forecast about you.
Fear or hype
Menopause content online swings between catastrophe and miracle cure, because both sell. We aim for the boring middle: what the evidence says, how confident it is, and what is still genuinely uncertain.
How AI is used — in the writing and in the app
We use AI tooling as a drafting and editing aid. Every published page is read, fact-checked against the cited sources, and edited by a human on the HRT AI team before it goes live. No page is generated and published unread. If you find a claim that does not match its source, tell us at contact@hrtai.app and we will correct it and note the change.
Inside the app, the weekly summary is a description of your own log, not an opinion about your treatment. It names what changed, what held steady, and one question worth raising at your next appointment. It does not diagnose, does not score your regimen, and does not suggest a dose. That constraint is a product decision, not an accident — the same line this page draws around our writing is drawn around the software.
Who the guides are written for
Most menopause content is written as though every reader is a cisgender woman in her early fifties going through a natural transition. That leaves out a lot of people who need the same information: those in surgical menopause after oophorectomy, those with premature ovarian insufficiency in their twenties and thirties, and people on gender-affirming hormone therapy, who track many of the same things for different reasons.
We write for all of those readers. Where a fact applies to one group and not another, we say which. Where the evidence base for a group is thinner — and for POI and for long-term gender-affirming care, it genuinely is — we say that too rather than borrowing conclusions from a population that was not studied.
Corrections and conflicts of interest
HRT AI makes money from the App Store. We sell no hormones, no supplements, no tests, and no compounded preparations. We take no payment for coverage, and there are no affiliate links anywhere on this site. Our commercial interest is that you find the app useful enough to keep using — which is served by accurate writing, and damaged by the alternative.
To report an error, email contact@hrtai.app with the page and the claim. Substantive corrections are made in place and the review date is updated.